PEMF for
Costochondritis.

July 2026 · 8 min read · Clinical Protocol

What Is Costochondritis, and How Does It Develop?

Costochondritis is inflammation of the cartilage that connects the upper ribs to the breastbone (the costochondral junctions), most often at the second through fifth ribs. In most cases the cause is unknown (idiopathic), but it can appear after repetitive physical strain, heavy lifting, a prolonged cough following a respiratory infection, or local trauma. The pain arises from irritation and repeated strain of the cartilage and the surrounding soft tissue, sometimes with a local inflammatory and edema component. It is important to distinguish costochondritis — in which there is no visible swelling — from Tietze syndrome, which involves marked local swelling at the costochondral junction, usually at a single rib. Both are benign, but Tietze syndrome is rarer.

What Is PEMF, and What Is Its Role in Chest Wall Pain?

PEMF (Pulsed Electromagnetic Field) is a non-invasive treatment in which a pulsed magnetic field is delivered into the tissue. Mechanisms described in the literature include improved microcirculation, reduced edema, effects on inflammatory mediators, and reduced local nerve hypersensitivity. In costochondritis — a condition characterized by pain and irritation of cartilaginous and soft tissue — there is a clinical rationale for using PEMF as a complementary tool alongside relative rest and load reduction, aiming to support the reduction of pain and edema. PEMF does not replace medical diagnosis or basic conservative care; it integrates into it. Its main advantage for the patient is that it is comfortable, with no injections and none of the systemic side effects of medication.

How PEMF Supports Faster Recovery

From the patient's perspective, the goal of the complementary treatment is to ease pain and allow a fast, safe return to routine. PEMF is delivered while sitting or lying comfortably, requires no full undressing, and is completely painless. Because pain in costochondritis worsens with breathing and movement, reducing the pain allows deeper breathing and freer movement — breaking the pain–avoidance–stiffness cycle. Combining it with breathing guidance, gentle chest-wall stretching, and posture correction increases the benefit.

Why Does the Pain Worsen with Deep Breathing and Coughing?

The costochondral junctions move with every breath. When the cartilage is irritated and inflamed, any expansion of the chest — a deep breath, a cough, or a laugh — stretches the sensitive tissue and triggers sharp pain. This is why many patients adopt shallow breathing, which can worsen stiffness.

How Do You Tell Costochondritis Pain from Cardiac Pain?

The key distinguishing sign is tenderness on palpation: in costochondritis, pressing on the costochondral junction reproduces the pain, whereas cardiac pain is not worsened by palpation. However, this test does not replace medical evaluation — any chest pain requires a physician to rule out a cardiac cause before any treatment.

What Does the Research Say?

It must be stated up front: there is currently no dedicated controlled clinical trial of PEMF in costochondritis itself. The clinical rationale rests on general evidence for PEMF in joint and soft-tissue pain and on the mechanisms of action. In the 2025 multicenter RCT (n=91, 5 orthopedic clinics, PMC11914662), the PEMF group showed a 36% pain reduction versus 10% with standard care (p<0.0001), alongside roughly a 55% reduction in pain-medication use. That trial examined joint and soft-tissue pain in general — not costochondritis specifically — so it is extrapolated to the general tissue efficacy of the treatment. In addition, a review published in the Aesthetic Surgery Journal (Strauch et al., 2009, Albert Einstein College of Medicine, PubMed 19371845) describes PEMF easing soft-tissue pain and edema and promoting angiogenesis. Because costochondritis is characterized by tissue irritation and local edema, using PEMF as a complementary treatment is a reasonable clinical rationale — even though direct evidence for this specific condition is still limited.

Clinical Protocol

1. Session duration: about 30 minutes per session.
2. Frequency: 1–2 times per week (in the acute phase, up to 3, with a rest day between sessions).
3. Series length: minimum of 3 sessions to assess response; the series length is set by the practitioner's judgment and the patient's response, with initial improvement usually felt after several sessions.
4. Patient positioning: sitting or lying comfortably, with the anterior chest wall exposed; coil, waveform, and duty cycle are selected by the system according to the region and tissue depth.
5. Integration: breathing guidance, gentle stretching of the intercostal and chest muscles, posture correction, and reduction of repetitive mechanical loads.

PEMF is defined as a complementary therapeutic tool and does not replace the diagnosis or exclusion of cardiac/pulmonary causes of chest pain. PEMF systems are FDA cleared (510k) for pain and edema indications; use in costochondritis is derived from general soft-tissue efficacy and managed by clinical judgment.

Who Is It For — and Who Is It Less Suitable For?

Especially suitable for: patients with persistent or recurrent costochondritis that does not resolve with rest alone; patients who prefer a non-invasive option with no injections and no prolonged medication; patients sensitive to painkillers or with contraindications to anti-inflammatory drugs; and athletes seeking a controlled return to activity.

Contraindications — PEMF should not be used in:

• Pregnancy
• Carriers of a pacemaker or implanted electronic device
• Patients with epilepsy
• An area of active malignancy (consult the treating physician)
• Active infection or active bleeding in the treatment area

PEMF vs. Common Treatments for Costochondritis

PEMF does not compete with conservative care but complements it: NSAIDs and rest remain an accepted first line, and PEMF is added as a calming, non-invasive component to reduce pain and edema.

Frequently Asked Questions

Does PEMF cure costochondritis?

No. Costochondritis usually resolves on its own, and PEMF is a complementary treatment that may support the reduction of pain and edema alongside conservative care. It is not a miracle cure.

Is the treatment painful?

No. PEMF is entirely comfortable, with no injections and no pain. The patient sits or lies comfortably for about 30 minutes.

How many sessions are needed?

A minimum of 3 sessions is recommended to assess response. The series length is set by the practitioner's judgment and the patient's response, and initial improvement is usually felt after several sessions.

Can PEMF be combined with physiotherapy and medication?

Yes. PEMF integrates well with physiotherapy, stretching, breathing guidance, and anti-inflammatory medication. It is meant to integrate into the treatment plan, not to replace it.

Can costochondritis recur?

Yes, especially if the load factors persist (prolonged coughing, repetitive strain, poor posture). Reducing loads and practicing breathing help lower the risk of recurrence.

Does PEMF replace a doctor's evaluation for chest pain?

Absolutely not. Any chest pain first requires medical evaluation to rule out a cardiac or pulmonary cause. PEMF is provided only after a physician has diagnosed costochondritis.

When to See a Doctor — Warning Signs

Seek urgent medical care if chest pain is accompanied by any of the following:

• Shortness of breath, pain radiating to the arm, jaw, or back, cold sweat, or nausea — suspicion of a cardiac event; go to the emergency room immediately
• Rapid heartbeat or dizziness with the chest pain
• Fever, redness, or warm swelling over the area — suspicion of infection
• Pain after significant chest trauma
• Worsening pain, or pain not improving despite treatment, or interfering with sleep and function

Over 70+ Israeli clinics serving a population of 9M — now expanding to the Philippines — have integrated PEMF into their treatment mix, offering patients a non-invasive, comfortable, drug-free option to ease chest wall pain and other tissue-pain conditions.

Sources

• 2025 multicenter RCT, n=91, 5 orthopedic clinics — PMC11914662 (general joint and soft-tissue pain; not specific to costochondritis).
• Strauch B. et al., 2009, Aesthetic Surgery Journal, Albert Einstein College of Medicine — PubMed 19371845 (review: PEMF for soft-tissue pain, edema, and angiogenesis).